Page 48 - Product Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Accesswire. The AP news staff was not involved in its creation. Abivax Hosting Key Opinion Leader Webinar on ABX464 for the Treatment of Ulcerative Colitis April 19, 2021 GMT The Webinar takes place on Tuesday, April 20, 2021 at 7:30am EDT (1:30pm CEST)PARIS, FRANCE / ACCESSWIRE / April 19, 2021 / Abivax SA (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company developing novel therapies that ... The Webinar takes place on Tuesday, April 20, 2021 at 7:30am EDT (1:30pm CEST)PARIS, FRANCE / ACCESSWIRE / April 19, 2021 / Abivax SA (Euronext Pa...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Avadel Presents New Data from its Pivotal REST-ON Phase 3 Trial of FT218, once-nightly sodium ... Avadel Pharmaceuticals plcApril 17, 2021 GMT Secondary endpoint data for once-nightly FT218 further supports previously announced topline data demonstrating clinically meaningful results at 6 g, 7.5 g, and 9 g doses DUBLIN, Ireland, April 17, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium o...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Ehave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping Technology EhaveApril 16, 2021 GMT MIAMI, April 16, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to launch brain mapping ketamine clinical trials using Brain Scientific technology later this year. The clinical trial will establish the statistical correlation between the ketamin...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Amgen Successfully Completes Acquisition Of Five Prime Therapeutics April 16, 2021 GMT Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/) THOUSAND OAKS, Calif., April 16, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prime Therapeutics (NASDAQ:FPRX), a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, for $38.00 ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. New England Journal of Medicine publishes exploratory study showing signals of positive ... COMPASS Pathfinder Ltd.April 15, 2021 GMT London, UK, April 15, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed a study published in the  New England Journal of Medicine (NEJM) yesterday, which showed signals of positive activity in COMP360 psilocybin com...